Pharmasoft
Clinical trials sponsored by Pharmasoft, explained in plain language.
-
Stroke recovery drug shows promise in major trial
Disease control CompletedThis study tested whether adding Mexidol to standard stroke care helps people recover better after a first ischemic stroke. 304 adults who had a stroke within 48 hours were given either Mexidol or a placebo for about 10 weeks. Researchers measured disability, neurological symptom…
Phase: PHASE3 • Sponsor: Pharmasoft • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Could a Mitochondria-Boosting drug help save sight in glaucoma?
Disease control CompletedThis completed Phase 4 trial tested the drug Mexidol in 80 people with advanced primary open-angle glaucoma. The goal was to see if the drug could improve the function of mitochondria in cells and protect the optic nerve. Participants were randomly assigned to receive Mexidol or …
Phase: PHASE4 • Sponsor: Pharmasoft • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Can mexidol help glaucoma patients see better?
Disease control CompletedThis study tested different doses of the drug Mexidol in 102 adults with moderate to advanced open-angle glaucoma. The goal was to see if the drug could improve vision compared to a placebo. Participants took the drug or placebo in a sequence over several months, and their vision…
Phase: PHASE2 • Sponsor: Pharmasoft • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Could a russian drug boost brain function in chronic ischemia?
Disease control CompletedThis study tested whether the drug Mexidol (given first as injections, then as pills) can improve thinking and memory in people with chronic cerebral ischemia, a condition where the brain doesn't get enough blood flow. 318 adults aged 40-90 with mild to moderate cognitive impairm…
Phase: PHASE3 • Sponsor: Pharmasoft • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC